PHARMA

0.250

(%)

Share Consolidation

PHARMANIAGA BERHAD

Entitlement subject Share Consolidation
Entitlement description
CONSOLIDATION OF EVERY 5 EXISTING ORDINARY SHARES IN PHARMANIAGA BERHAD ("PHARMANIAGA" OR "COMPANY") ("PHARMANIAGA SHARE(S)") INTO 1 PHARMANIAGA SHARE ("CONSOLIDATED SHARE(S)") ("SHARE CONSOLIDATION")
Ex-Date 08 Jun 2026
Entitlement date 09 Jun 2026
Entitlement time 05:00 PM
Financial Year End 31 Dec 2026
Share transfer book & register of members will be  to  closed from (both dates inclusive) for the purpose of determining the entitlement
a.Securities transferred into the Depositor's Securities Account before 4:30 pm in respect of transfers 09 Jun 2026
b.Securities deposited into the Depositor's Securities Account before 12:30 pm in respect of securities exempted from mandatory deposit
c. Securities bought on the Exchange on a cum entitlement basis according to the Rules of the Exchange.
Number of new shares/securities issued (units)
(If applicable)
Entitlement indicator Ratio
Par Value (if applicable)

Entitlement Details

Company Name Ratio
(New : Existing)
Available/Listing Date Fractional Entitlement
PHARMANIAGA BERHAD 1.0000 : 5.0000 10 Jun 2026 Round Down / Fraction Disregard

Registrar or Service Provider name, address, telephone no TRICOR INVESTOR & ISSUING HOUSE SERVICES SDN BHD
Unit 32-01, Level 32, Tower A,
Vertical Business Suite, Avenue 3, Bangsar South,

No. 8, Jalan Kerinchi

59200 Kuala Lumpur

Wilayah Persekutuan

Malaysia

Tel:0327839299
Fax:0327839222


Remarks :
The Share Consolidation involves the consolidation of every 5 existing Pharmaniaga Shares into 1 Consolidated Share as at 5:00 p.m. on 9 June 2026, being the entitlement date for the Share Consolidation.

The actual number of Consolidated Shares to be issued will depend on the issued share capital of Pharmaniaga on the Entitlement Date. Fractional entitlements for the Consolidated Shares arising from the Share Consolidation, if any, shall be disregarded and/or dealt with by the Board of Directors of the Company in its absolute discretion as it may deem fit and expedient and in the best interest of the Company.

The Consolidated Shares will be listed and quoted on the Main Market of Bursa Malaysia Securities Berhad ("Bursa Securities") on 10 June 2026, being the next market day after the Entitlement Date ("Listing Date").

The notices of allotment of the Consolidated Shares will be issued and despatched to the entitled shareholders of Pharmaniaga within 4 market days after the Listing Date.

This announcement is dated 20 May 2026.


Announcement Info

Company Name PHARMANIAGA BERHAD
Stock Name PHARMA
Date Announced 20 May 2026
Category Entitlement(Notice of Book Closure)
Reference Number ENT-20052026-00008
Corporate Action ID MY260520SPLR0001